share_log

Evercore ISI Group Upgrades Augmedix to Outperform, Raises Price Target to $5

Moomoo 24/7 ·  Apr 9 15:18

Evercore ISI Group analyst Elizabeth Anderson upgrades Augmedix (NASDAQ:AUGX) from In-Line to Outperform and raises the price target from $4.5 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment